The Centers for Disease Control and Prevention (CDC) Division of Viral Hepatitis has released its 2013 Viral Hepatitis Surveillance Report, providing the latest data on hepatitis A, B, and C in the U.S. While hepatitis C has traditionally been predominant among Baby Boomers, the new report shows that HCV incidence is rising fastest among young people. But a recently published related study suggests that formal surveillance methods may grossly underestimate the number of people newly infected with HCV.
Long-awaited results from the START study show that people with HIV who start antiretroviral therapy (ART) soon after diagnosis, while their CD4 T-cell count is still high, have a lower risk of illness and death than those who wait, according to a May 27 announcement from the National Institute of Allergy and Infectious Diseases.
HIVandHepatitis.com coverage of the 50th European Association for the Study of the Liver International Liver Congress (EASL 2015) in Vienna, April 22-26, 2015.
Conference highlights include interferon-free hepatitis C treatment for people with advanced disease, experimental HCV antivirals, hepatitis B and delta, and management of liver disease complications.
HIVandHepatitis.com coverage of the 2015 Conference on Retroviruses and Opportunistic infections (CROI 2015), February 23-26, 2015, in Seattle.
Conference highlights include PrEP and HIV treatment as prevention, hepatitis C treatment for HIV/HCV coinfected people, new antiretroviral drugs, HIV cure research, HIV-related conditions, TB, Ebola virus, and access to care.